Weight loss in the GCC is no longer a narrow conversation around gyms, diets or appearance. A broader boom is emerging as three forces come together: a large population-level burden of obesity and diabetes, the expansion of weight management into managed consumer-health journeys, and the entry of medical weight-loss solutions such as GLP-1 drugs. This is shifting weight management from a lifestyle-led category into a broader consumer-health and metabolic-care market.
The opportunity is significant, but the category is also becoming more complex. As consumers move from self-directed diets and fitness programs toward nutrition products, digital tools, coaching, clinics and prescription-led solutions, the key question is whether the market can deliver safe, supervised and sustainable outcomes -not just faster weight reduction.